Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Industry Could Help Asia Establish Adverse Event Monitoring Systems – DIA Conference

This article was originally published in PharmAsia News

Executive Summary

As countries like India and China reform their pharmacovigilance systems, opportunities are increasing for improved relationships between international companies and regulatory authorities despite stagnant harmonization efforts

You may also be interested in...

Bristol/Accenture Launch Pharmacovigilance Center In India

Bristol-Myers Squibb and Accenture have established a center for pharmacovigilance as part of Accenture's Life Sciences Centers of Excellence in Chennai, India, Accenture announced Sept. 13

Australia, New Zealand Postpone Plans For Joint Medicines Agency

Australia and New Zealand's plan to establish a joint agency to regulate therapeutic products has been shelved after New Zealand lawmakers failed to support legislation to approve the country's participation in the venture

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts